Target intelligence / Profile preview

SLC17A6 divergent transcript (SLC17A6-DT)

Target
SLC17A6-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript
01

Overview

SLC17A6-DT (SLC17A6 divergent transcript) is a long non-coding RNA transcribed from a locus adjacent to the SLC17A6 gene, which encodes vesicular glutamate transporter 2. Divergent lncRNAs are a subclass of long non-coding RNAs that arise by transcription from promoters near protein-coding genes, often in an antisense or bidirectional manner. These lncRNAs can regulate the expression of nearby genes through chromatin remodeling, transcriptional interference, or recruitment of epigenetic regulators, as demonstrated by molecular analogs like GATA3-AS1[2]. However, SLC17A6-DT itself does not have experimentally validated biological function, targetability, or disease relevance. The existence, sequence, and regulatory impact of SLC17A6-DT as a distinct entity remain putative, requiring further validation. It is not recognized as a therapeutic target, receptor, enzyme, or transporter[2].

Other names
lncRNA-GluGlutamate signaling associated lncRNASLC17A6-DTSLC17A6 divergent transcriptglutamate signaling associated lncRNA
02

Biological functions

Gene expression regulation (putative, by analogy to other divergent lncRNAs)Epigenetic modulation (speculative)
03

Disease associations

Other

Beyond the preview

Go deeper on SLC17A6 divergent transcript (SLC17A6-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC17A6 divergent transcript (SLC17A6-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call